Altered disposition of pravastatin following concomitant drug therapy with cyclosporin A in transplant recipients.
Regazzi
M B
MB
Department of Pharmacology, I.R.C.C.S. Policlinico S. Matteo, Pavia, Italy.
Iacona
I
I
Campana
C
C
Raddato
V
V
Lesi
C
C
Perani
G
G
Gavazzi
A
A
Viganò
M
M
D000328:Adult; D000906:Antibodies / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000097:blood / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D016027:Heart Transplantation / Q000276:immunology* / Q000502:physiology; D006801:Humans; D007165:Immunosuppression Therapy; D008297:Male; D008875:Middle Aged; D017035:Pravastatin / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D011241:Prednisone / Q000627:therapeutic use
D000906:Antibodies; D016572:Cyclosporine; D017035:Pravastatin; D001379:Azathioprine; D011241:Prednisone